Depletion of a certain type of stem cell in the womb lining during pregnancy could be a significant factor behind miscarriage, according to a study by Warwick Medical School researchers.

We're delighted that our new Interdisciplinary Biomedical Research Building, which we will share with the School of Life Sciences, is now complete, bringing to life Warwick's commitment to delivering world-leading research in neuroscience, microbiology and infection, cell biology, and disease models.

Rachel Spencer (GP Academic Clinical Lecturer with UAPC) has been awarded a highly competitive NIHR Advanced Fellowship. This award is for £850,000 over four years and is the largest funding ever to be handled by Coventry and Rugby CCG.

We are pleased to share news that eight members of the WMS community have secured Fellowships with the University's Institute of Engagement.

Warwick Medical School continues to be proud of the contribution our medical students are making during the ongoing Covid-19 pandemic.

In a new study from Warwick Medical School, the effectiveness of three alternatives to CPR were examined, and it was concluded that none were beneficial.

BMJ Article

It is with sadness that we share with you the news that one of our alumni, Rolland Iriarte has recently died. He graduated from the MB ChB programme in 2010 and will be remembered as a gregarious, kind and caring man.

On the UN's International Day of Women and Girls in Science, the University spoke to some our researchers and asked them about their hopes for their research and the importance of equality in their chosen field.

A new spin out company has been awarded funding from innovateUK to develop new frozen cell products. The company will use technology developed in the Gibsongroup which uses synthetic polymers to protect cells (and other biologics) during freezing, and to make them easier to transport and deliver. The company is being led by a postdoc in the group, Dr Tom Congdon.
Read the press release here
Read about the group’s research here

Congratulations to Professor Felicity Boardman who has been made a Foundation Fellow of the Warwick Institute of Engagement.

Congratulations to Professor Sophie Staniszewska who has been made a Foundation Fellow of the Warwick Institute of Engagement. Sophie says becoming a Foundation Fellow creates 'a great link for us and a chance to further embed involvement and engagement in our teaching and research'.

Dr Jean-Pierre Laake, a final year MB ChB student at WMS, who has continued to work as an epidemiologist alongside his studies, is highlighting the need to support good mental health in older adults during the winter months.

Congratulations to WMS PhD student Liz Corrigan who has been included in the New Year Honours List for her contribution to patient care during the COVID-19 pandemic.

The eyes of the world turned to Coventry and Warwickshire this month as the very first patient to receive the Pfizer Covid-19 vaccine (outside of a clinical trial) did so at our partner site, University Hospital Coventry.

While working on a Covid 19 ward medical student Matthew Thompson came up with the idea of a photography project documenting NHS workers labouring during the pandemic. The results of his photographic observations can be seen in his work 'Humans of the Pandemic.' Read more about his work here.

Sci Dev Net (26.11.2020) – ‘COVID-19 control measures choking rural, slum dwellers’. Professor Frances Griffiths, the study’s co-author and a professor at the UK-based Warwick Medical School, tells SciDev.Net that slum dwellers were already disadvantaged by unreliable water supply, poor provision of toilets and makeshift housing in the slum communities and there is a danger of them being deprived further by COVID-19 control restrictions.

Thank you to some MBChB unsung heroes who have been keeping things running by providing large numbers of training sessions to equip teachers in GP, in the community and at WMS for online working; Sue Davies, Catherine Bennett, Imogen Davis, Cath Fenn, Clare Blackburn and Jan Cooper. The wheels would have fallen off without you!

The GibsonGroup, as part of a large BBSRC/Innovate funded collaboration have published their latest results into using nanomaterials to probe glycan-binding events. In this collaborative work, a combined chemical and enzymatic synthetic route was exploited to generate glycans which could be attached to nanoparticles for glycan/lectin screening - a platform technology developed by the GibsonGroup. Using this approach, it was shown that selective addition of fluorine atoms allow selective binding of galectins which is not possible using natural disaccharides, and may offer a route for targeting therapies and diagnostics. https://doi.org/10.1039/D0SC05360K

One of the key questions in predicting the course of the COVID-19 pandemic is how well and for how long the immune response to the virus protects people from reinfection. The Robb group modelled early SARS-CoV-2 infection and fatality data from different regions around the world to predict how many reinfection cases would be expected if there was no immunity to the disease. Numerous serological studies now support the conclusion that short-term immunity to the virus exists. doi:10.2196/21168

Congratulations to the 20 current Warwick Medical School professors who were acknowledged in Stanford University’s world-wide list of researchers that recognises the top 2% of global leading scientists.

Ines Kander, who has been awarded a PhD in Health Sciences for their PhD on ‘Care Pathways in Traumatic Brain Injury’. Ines was supervised by Diane Playford in the division of Health Sciences and Sudakshina Lahiri

The College of Pathologists' annual International Pathology Day Conference recognises and celebrates the contribution and achievements of pathology and laboratory medicine services that work to address global health challenges and improve the health outcomes of global communities.

Scientists, led by Dr Nicole Robb, have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes. The test uses artificial intelligence to distinguish between microscope images of fluorescent viruses in throat swab samples. Unlike other technologies that detect a delayed antibody response or that require time-consuming sample preparation such as viral lysis or amplification, the new test quickly detects intact virus particles; meaning the assay is simple, fast and has the potential to be carried out in non-laboratory conditions. Read about the research here

The GibsonGroup have collaborated with immunologists at Nottingham to develop immune-instructive materials. Using the GibsonGroups technology for immobilising glycans (sugars) onto surfaces, they were able to screen for specific mixtures of glycans which modulated the behaviour of dendritic cells - key components of our immune system. This work shows that the incorporation of synthetic glycomaterials could be useful for the development of advanced implantable materials or in regenerative medicine. Read about the research here